SCHEMBL20133702

SCHEMBL20133702

COC(=O)c1cc(NC2CCN(c3ccccc3Cl)CC2)c(C)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.47
RPTOR Q8N122 4/20 0.47
MLST8 Q9BVC4 4/20 0.47
MALT1 Q9UDY8 1/20 0.45
EHMT2 Q96KQ7 1/20 0.43
WDR5 P61964 1/20 0.43
RBP4 P02753 1/20 0.43
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 2/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
NOTUM Q6P988 1/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HSP90AA1 P07900 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133703 0.89 MTOR (0.49) MTORRPTORMLST8MALT1EHMT2
SCHEMBL20129687 0.88 MAPT (0.49) MTORRPTORMLST8EHMT2ALDH1A1
SCHEMBL20129666 0.86 MTOR (0.62) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20141600 0.85 MAPT (0.49) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20133697 0.84 KDM4E (0.52) EHMT2ALDH1A1KMT2ARAB9AMEN1
SCHEMBL20133737 0.84 MTOR (0.48) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20133589 0.84 MTOR (0.61) MTORRPTORMLST8EHMT2ALDH1A1
SCHEMBL20133856 0.81 MTOR (0.56) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL20133751 0.80 MTOR (0.72) MTORRPTORMLST8ALDH1A1L3MBTL1
SCHEMBL20133548 0.80 MTOR (0.56) MTORRPTORMLST8ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.